Aurobindo Pharma Complete Financial Statements

AUROPHARMA • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015

Complete Financial Data Export

Export complete financial statements for Aurobindo Pharma (AUROPHARMA). Downloads include all available records across all periods. For market performance, see the AUROPHARMA stock price today .

Profitability Ratios

Net Profit Margin 10.14% 2025 data
EBITDA Margin 20.96% 2025 data
Operating Margin 20.00% 2025 data
Return on Assets 1.70% 2025 data
Return on Equity 2.60% 2025 data

Balance Sheet Ratios

Current Ratio 11.06 2025 data
Debt to Equity 1.52 2025 data
Equity Ratio 65.58% 2025 data
Asset Turnover 0.17 2025 data

Year-over-Year Growth Analysis

Comparing Sept 2024 vs Sept 2025
Revenue Growth
+7.4%
Year-over-Year
Net Profit Growth
+3.8%
Year-over-Year
EBITDA Growth
+12.8%
Year-over-Year
Expense Growth
+6.1%
Year-over-Year
Assets Growth
+10.5%
Year-over-Year
Equity Growth
+9.4%
Year-over-Year
Liabilities Growth
+10.5%
Year-over-Year
Operating Cash Flow Growth
+61.2%
Year-over-Year
Investing Cash Flow Growth
+56.0%
Year-over-Year
Financing Cash Flow Growth
-85.0%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Mar 2020 Jun 2020 Dec 2020 Sept 2019 Mar 2019 Jun 2019 Dec 2019 Sept 2018 Mar 2018 Jun 2018 Dec 2018 Sept 2017 Mar 2017 Jun 2017 Dec 2017 Sept 2016 Mar 2016 Jun 2016 Dec 2016 Sept 2015 Mar 2015 Jun 2015 Dec 2015
Revenue 8,359 8,516 7,899 7,783 7,628 7,679 8,052 7,339 6,514 6,907 7,434 5,731 5,844 6,218 6,481 5,987 6,071 5,802 6,089 6,432 6,108 5,951 9,300 5,539 5,234 5,377 5,830 4,694 4,033 4,226 5,242 4,366 3,625 3,645 4,302 3,742 3,710 3,728 3,871 3,324 3,151 3,272 3,450
Expenses 6,608 6,622 6,265 6,230 6,042 5,949 6,401 5,846 5,477 5,772 5,753 4,950 5,002 5,303 5,453 4,766 4,735 4,502 4,993 5,071 4,862 4,679 5,011 4,473 4,271 4,311 4,701 3,792 3,261 3,539 4,208 3,319 2,920 2,845 3,311 2,847 2,885 2,878 3,011 2,586 2,506 2,574 2,688
EBITDA 1,752 1,894 1,634 1,553 1,585 1,730 1,652 1,493 1,037 1,135 1,681 781 842 914 1,027 1,220 1,335 1,300 1,096 1,361 1,247 1,271 4,290 1,066 963 1,066 1,130 902 772 687 1,033 1,047 704 800 992 895 825 851 860 738 645 698 762
Operating Profit Margin % 20.00% 21.00% 20.00% 19.00% 19.00% 20.00% 19.00% 18.00% 14.00% 15.00% 21.00% 13.00% 14.00% 14.00% 15.00% 19.00% 21.00% 21.00% 17.00% 20.00% 20.00% 20.00% 21.00% 19.00% 18.00% 20.00% 19.00% 19.00% 18.00% 15.00% 19.00% 24.00% 18.00% 21.00% 22.00% 23.00% 21.00% 22.00% 22.00% 22.00% 20.00% 21.00% 22.00%
Depreciation 429 444 406 382 354 404 419 418 346 327 423 298 254 280 321 294 266 280 299 257 232 256 277 243 187 241 250 164 157 155 163 132 100 131 138 110 111 106 111 93 85 89 99
Interest 95 115 98 113 89 111 119 68 56 57 76 25 9 15 45 10 18 13 16 16 32 21 20 41 50 50 37 35 25 30 48 17 14 17 19 18 25 21 14 68 21 31 9
Profit Before Tax 1,276 1,335 1,207 1,208 1,230 1,324 1,200 1,076 730 812 1,262 523 594 679 680 968 1,061 1,018 794 1,193 1,078 1,084 4,005 864 816 863 938 787 651 571 917 979 649 709 902 830 761 786 796 631 557 634 717
Tax 428 432 383 391 323 406 354 324 224 242 323 113 18 159 189 271 260 248 190 386 229 301 1,058 224 231 228 233 175 122 116 205 198 117 191 307 224 206 201 218 178 153 162 173
Net Profit 848 903 824 817 907 918 846 752 506 570 940 410 576 520 491 697 801 770 604 807 849 783 2,948 640 585 636 705 611 529 456 712 781 532 518 595 606 555 585 579 453 403 472 545
Earnings Per Share (₹) 14.61 15.56 14.20 14.00 15.51 15.69 14.56 12.83 8.64 9.74 16.04 6.99 9.84 8.88 8.38 11.89 13.67 13.14 10.32 13.78 14.50 13.32 50.31 10.92 9.99 10.85 12.04 10.44 9.02 7.78 12.15 13.33 9.10 8.85 10.16 10.41 9.49 9.99 9.88 7.77 13.84 16.18 9.32

Related Pages for Aurobindo Pharma

Additional stock information and data for AUROPHARMA

Aurobindo Pharma share price performance
AUROPHARMA quarterly results
AUROPHARMA intrinsic value calculation
Aurobindo Pharma P/B ratio trends
AUROPHARMA earnings multiple
AUROPHARMA market capitalization
AUROPHARMA price range
AUROPHARMA dividend track record

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 49,785 45,072 39,890 33,922 33,854 28,928 26,454 21,101 16,249 15,920 12,915
Current Assets 27,163 23,772 21,460 18,123 19,824 16,413 15,332 12,178 9,206 10,294 8,299
Fixed Assets 14,794 14,493 11,024 10,532 9,374 9,397 8,475 6,521 4,834 4,180 3,706
Capital Work in Progress 4,900 3,869 5,390 3,747 3,062 1,986 1,669 1,583 1,458 848 420
Investments 252 372 543 997 591 555 360 312 246 123 20
Other Assets 29,839 26,338 22,934 18,645 20,828 16,991 15,951 12,686 9,712 10,769 8,770
LIABILITIES
Total Liabilities 49,785 45,072 39,890 33,922 33,854 28,928 26,454 21,101 16,249 15,920 12,915
Current Liabilities 2,456 3,022 1,544 1,192 1,260 718 541 753 270 790 1,596
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 32,647 29,851 26,852 24,574 21,929 16,825 13,892 11,682 9,374 7,290 5,182
Share Capital 58 59 59 59 59 59 59 59 59 59 29
Reserves & Surplus 32,595 29,784 26,781 24,517 21,871 16,766 13,832 11,622 9,313 7,229 5,127

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 3,925 2,435 2,387 5,017 3,329 4,381 1,651 1,955 3,279 1,420 1,237
Investing Activities -1,866 -4,242 -3,971 -3,211 597 -1,563 -2,904 -1,927 -1,787 -1,446 -1,017
Financing Activities 120 800 1,814 -2,969 -1,365 -1,947 1,919 864 -1,915 365 93
Net Cash Flow 2,178 -1,007 230 -1,164 2,561 871 666 892 -424 340 313